Frankfurt - Delayed Quote EUR
Ascelia Pharma AB (7ZA.F)
0.2075
-0.0560
(-21.25%)
At close: April 25 at 8:06:40 AM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-62,844
-62,844
-126,792
-125,263
-116,559
Investing Cash Flow
--
--
47
-65
-38
Financing Cash Flow
115,187
115,187
-936
-1,100
184,871
End Cash Position
75,256
75,256
21,855
149,555
261,599
Capital Expenditure
--
--
--
-65
-38
Issuance of Capital Stock
105,324
105,324
--
295
199,483
Issuance of Debt
33,458
33,458
--
--
--
Repayment of Debt
-7,500
-7,500
--
--
--
Repurchase of Capital Stock
--
--
--
-295
-397
Free Cash Flow
-62,844
-62,844
-126,792
-125,328
-116,597
12/31/2021 - 12/11/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade